Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
casr.png
 
 
 
Hauptnavigation
  • Home
  • General Information
    • Newsletter
    • Outreach
    • Recruitment
    • Meetings
    • Publications
    • Awards
    • Previous Project Multifaceted CaSR
    • Contact
  • Projects
    • Project 1 - CaSR-mediated signalling in colonocytes
    • Project 2 - Evaluation of CaSR - based therapeutics in prevention of tumourigenesis and metastatic potential in colorectal cancer
    • Project 3 - Role of the CaSR in inflammatory lung diseases
    • Project 4 - Evaluation of CaSR-targeted drugs for the treatment of neuroblastoma
    • Project 5 - Delineation of CaSR signalling in primary cells and cell lines with native receptor expression
    • Project 6 - Role of the calcium-sensing receptor (CaSR) in glucose homeostasis
    • Project 7 - Cell-specific CaSR signaling
    • Project 8 - Targeting CaSR in human skeletal muscle cells to delay sarcopenia development
    • Project 9 - Evaluation of CaSR-targeted drugs for the treatment of diabetes mellitus
    • Project 10 - Role of the CaSR in early bone metastasis of breast cancer cells and evaluation of CaSR - based therapeutics in prevention or delay of metastasis formation
    • Project 11 - Ligand-biased G-protein activation by CaSR
    • Project 12 - The role of CaSR in AD pathomechanisms
    • Project 13 - In silico analysis of CaSR-ligand interaction
    • Project 14 -Generation, validation and application of algorithms for tissue segmentation used in advanced tissue cytometry
  • People
    • ESR Fellows
    • Academic Beneficiaries
    • Non-academic Beneficiaries
    • Partner Organisations
    • Coordination Team
    • Advisory Board
  • Training
    • Secondments
    • E-Learning Modules
    • 1st ETN School: CaSR: Molecular and clinical aspects
    • 2nd ETN School: Translational drug Research
    • 3rd ETN School: Introduction to Academic Teaching
    • 4th ETN School: Self-presentation & Communication
    • 5th ETN School: Research, Innovation Entrepreneurship
 
Training / 2nd ETN School: Translational drug Research
 
Subnavigation
  • Secondments
  • E-Learning Modules
  • 1st ETN School: CaSR: Molecular and clinical aspects
  • 2nd ETN School: Translational drug Research
  • 3rd ETN School: Introduction to Academic Teaching
  • 4th ETN School: Self-presentation & Communication
  • 5th ETN School: Research, Innovation Entrepreneurship


Inhaltsbereich

2nd ETN School: Translational drug Research

2nd ETN School: “Translational drug Research”

Lead: H. Bräuner-Osborne (UCPH)

15-19.05.2017

Objectives: Overview on drug discovery and development; CaSR-specific case histories; Basics of imaging mass spectrometry.

Open to external students

ECT: 4.0

WS: Fundamentals of Drug Discovery and Development: (responsible E.F. Nemeth, K.Seuwen, E. Durchschlag): Day 1 • Identifying a drug target; • Target-based vs phenotypic screening, compound libraries and molecular modelling; • Selecting the clinical candidate; pharmacokinetics; • Primary and secondary pharmacology, toxicology; • Design and performance of clinical trials in conformance with EMEA and GCP guide-lines; Day 2 • Discovery and development of calcimimetics for hyperparathyroidism, second generation calcimimetics; • Calcilytics for osteoporosis; • drug repurposing of calcilytics for rare diseases; • Next generation of calcimimetics.

Protein Structure-Based Drug Design: (Responsible: F. Bruggeman, L. Pugliese): • Pipeline of drug target selection; • Drug design via protein modelling, drug synthesis, and high-throughput testing; • homology modelling and dynamical behaviour of GPCRs.

WS: Imaging: (responsible A. Cissoko and R. Ecker) • Imaging mass spectrometry workflow i.e. sample preparation, matrix application, instrumentation, and image and data processing.

WS: Management Systems: (responsible A. Hollo-Tas) • Evaluation and discussion session summing up what has been learned during the e-Learning Course that preceded it.

Here to the Programme

 

2nd ETN School on Translational Drug Research took place in Copenhagen 15th-19th May 2017.

Prof. Hans Bräuner-Osborne, from the School of Pharmaceutical Sciences at the University of Copenhagen, hosted the 2nd ETN school.  "Interesting and high quality lectures on translational drug research have been presented. The format and setting was ideal to interact and share knowledge and most important it allowed the ESRs to establish stronger connections not only as colleagues!  I am confident that we are really working as a robust network that can make important progress in the CaSR’s research" (Maria Lo Giudice, ESR at Biotalentum)

 
Drucken
 

Quick Links

 
-- News Archive
-- Previous Project Multifaceted CaSR
-- Papers authored by the Multifaceted CaSR Fellows
-- Contact
 
 

Featured

 
 
 
 
 
 
 
© MedUni Wien | Publishing information | Terms of use | Data Protection | Accessibility | Contact